Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter
|ClinicalTrials.gov Identifier: NCT00688610|
Recruitment Status : Completed
First Posted : June 3, 2008
Last Update Posted : January 28, 2009
Antibiotics in patients with acute respiratory tract infections in primary care in consideration of procalcitonin as additive parameter.
The purpose of this study is to compare the ordinary manner of antibiotic- prescription with the prescription in consideration of procalcitonin-value in patients with acute respiratory tract infections.
|Condition or disease||Intervention/treatment||Phase|
|Respiratory Tract Infection||Other: laboratory value procalcitonin||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||571 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Antibiotics in Patients With Acute Respiratory Tract Infections in Primary Care in Consideration of Procalcitonin as Additive Parameter|
|Study Start Date :||November 2007|
|Actual Primary Completion Date :||June 2008|
|Actual Study Completion Date :||June 2008|
Other: laboratory value procalcitonin
A. attending physician includes patient with acute respiratory infection in study, indicates antibiotic prescription and collects procalcitonin-value. Waits for decision from laboratory either "change of decision" or "retention of decision". In case of "change decision": antibiotic is not recommended, patient shall not take antibiotic. In case of "retention of decision": patient may take the antibiotic.
B. attending physician includes patient with acute respiratory infection in study, indicates NO antibiotic and collects procalcitonin-value. Waits for decision from laboratory either "change of decision" or "retention of decision". In case of "change decision": antibiotic is recommended, patient has to be informed about. In case of "retention of decision": no change.
- days with significant impairment due to acute respiratory tract infection [ Time Frame: 14 to 28 days after infection ]
- number of antibiotic prescriptions [ Time Frame: 28 days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00688610
|Medical School Hannover, Department Pneumology|
|Hannover, Germany, 30625|
|Principal Investigator:||Olaf Burkhardt, Dr.||Medical School Hannover|